U.S. clinical trial results show Novavax vaccine is safe and prevents COVID-19
The investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease.
Full Article
U.S. clinical trial results show Novavax vaccine is safe and prevents COVID-19
Upworthy
0 shares
1 views
You might like
Related news coverage
Novavax COVID-19 vaccine shows over 90% efficacy in the U.S. late-stage trial
Novavax Inc (NASDAQ: NVAX) said on Monday its candidate COVID-19 vaccine showed 93% efficacy in its U.S. late-stage trial. The..
Invezz
Novavax says COVID-19 vaccine 90% effective, also tested in combination with influenza jab
Novavax, Inc. (NASDAQ:NVAX) said its COVID-19 vaccine was 90% effective in late-stage trials and was also tested in combination..
Proactive Investors